October 20, 2026 at 10:06 AM UTC
Rapport Therapeutics, Inc. issues Regulation FD disclosure
Rapport Therapeutics, Inc. filed an 8-K covering a Regulation FD disclosure and other material corporate events. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: October 20, 2026 at 10:05 AM UTC
Open official source